LYMPHOCYTOSIS side effect
What is LYMPHOCYTOSIS ?LYMPHOCYTOSIS : Xolair Side Effects Report #5664862-2
Consumer or non-health professional from SWITZERLAND reported XOLAIR problem on Mar 10, 2008. Female patient, 40 years of age, was diagnosed with asthma and was treated with XOLAIR. After drug was administered, patient experienced the following problems/side effects: lymphocytosis, respiratory tract infection, . XOLAIR dosage: unknown. Patient recovered.
LYMPHOCYTOSIS : Xolair Side Effects Report #5547807-5
XOLAIR problem was reported by a Consumer or non-health professional from SWITZERLAND on Nov 29, 2007. Female patient, 40 years of age, was diagnosed with asthma and was treated with XOLAIR. After drug was administered, patient experienced the following problems/side effects: lymphocytosis, respiratory tract infection, . XOLAIR dosage: unknown. Patient recovered.
LYMPHOCYTOSIS : Raptiva Side Effects Report #5447633-1
Pharmacist from UNITED STATES reported RAPTIVA problem on Sept 06, 2007. Male patient, weighting 168.4 lb, was diagnosed with psoriasis and was treated with RAPTIVA. After drug was administered, patient experienced the following problems/side effects: lymphocytosis, neck mass, neutropenia, thrombocytopenia, . RAPTIVA dosage: 0.7 MG/KG SUBQ X 1 FROM 1MG/KG SUBQ WEEKLY 3-4 MONTHS. Patient was hospitalized. Patient recovered.
LYMPHOCYTOSIS : Lyrica Side Effects Report #5447856-1
LYRICA problem was reported by a Physician from GERMANY on Aug 29, 2007. Female patient was diagnosed with meralgia paraesthetica and was treated with LYRICA. After drug was administered, patient experienced the following problems/side effects: lymphocytosis, . LYRICA dosage: unknown. Patient recovered.
LYMPHOCYTOSIS : Raptiva Side Effects Report #5676586-6
Physician from UNITED STATES reported RAPTIVA problem on Mar 21, 2008. Female patient was diagnosed with psoriasis and was treated with RAPTIVA. After drug was administered, patient experienced the following problems/side effects: lymphocyte morphology abnormal, lymphocytosis, . RAPTIVA dosage: unknown. Patient recovered.
LYMPHOCYTOSIS : Escitalopram Side Effects Report #5516900-5
ESCITALOPRAM problem was reported by a Consumer or non-health professional from FRANCE on Oct 25, 2007. Male patient, 32 years of age, was diagnosed with depression and was treated with ESCITALOPRAM. After drug was administered, patient experienced the following problems/side effects: cutaneous vasculitis, lymphocytosis, no therapeutic response, skin toxicity, . ESCITALOPRAM dosage: 10 MG QD PO. Patient recovered.
LYMPHOCYTOSIS : Fosamax Side Effects Report #5583321-9
Consumer or non-health professional from UNITED STATES reported FOSAMAX problem on Dec 27, 2006. Female patient, 65 years of age, was diagnosed with osteoporosis and was treated with FOSAMAX. After drug was administered, patient experienced the following problems/side effects: hypothyroidism, lymphocytosis, osteonecrosis, periarthritis, . FOSAMAX dosage: 70 MG/WKY/PO. Patient recovered.
LYMPHOCYTOSIS : Sutent Side Effects Report #5382272-2
SUTENT problem was reported by a Consumer or non-health professional from ARGENTINA on June 27, 2007. Male patient, weighting 176.4 lb, was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: anaemia macrocytic, hypertension, lymphocytosis, palmar-plantar erythrodysaesthesia syndrome, . SUTENT dosage: unknown. During the same period patient was treated with NEURONTIN, MEPREDNISONE. Patient recovered.
LYMPHOCYTOSIS : Sutent Side Effects Report #5382272-2
Consumer or non-health professional from ARGENTINA reported SUTENT problem on June 27, 2007. Male patient, weighting 176.4 lb, was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: anaemia macrocytic, hypertension, lymphocytosis, palmar-plantar erythrodysaesthesia syndrome, . SUTENT dosage: unknown. During the same period patient was treated with NEURONTIN, MEPREDNISONE. Patient recovered.